insights_auto
Nega 1AE oshdi 3,51%?
Batafsil oʻrganishchevron_right
1AE:ETR
argenx SE
730,40 €
arrow_upward
+3,51%(+24,80) 1K
9-okt, 17:35:46 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto1AE tikeri uchun statistika yaratilmoqda...
Ochish
738,00 €
Yuqori
741,20 €
Past
721,40 €
Bozor kapitali
43,80 mlrd
Oʻrtacha hajm
78,00
Hajmi
221,00
P/E koeffitsiyenti
31,07
52 haftalik eng yuqori
922,00 €
52 haftalik eng past
574,20 €
Aksiya boʻyicha daromad
23,51 €
Xodimlar soni
2 ming
Ochish
738,00 €
Yuqori
741,20 €
Past
721,40 €
Bozor kapitali
43,80 mlrd
Oʻrtacha hajm
78,00
Hajmi
221,00
P/E koeffitsiyenti
31,07
52 haftalik eng yuqori
922,00 €
52 haftalik eng past
574,20 €
Aksiya boʻyicha daromad
23,51 €
Xodimlar soni
2 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
23 soat oldin
Could A Halted Sjögren Trial Alter The Investment Case For argenx Stock?
Yahoo Finance
·
1 kun oldin
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
1 kun oldin
Argenx stock sits at EUR 736.30 after a week of mixed trial news
Investing.com
·
2 kun oldin
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
argenx SE haqida